SETDB1 Antikörper
-
- Target Alle SETDB1 Antikörper anzeigen
- SETDB1 (SET Domain, Bifurcated 1 (SETDB1))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SETDB1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- SET domain, bifurcated 1
- Isotyp
- IgG
- Top Product
- Discover our top product SETDB1 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3 ,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- SETDB1 (SET Domain, Bifurcated 1 (SETDB1))
- Andere Bezeichnung
- SETDB1 (SETDB1 Produkte)
- Hintergrund
- Synonyms:KIAA0067, KMT1E Background:This gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.
- Molekulargewicht
- 210 kDa
- Gen-ID
- 9869
- UniProt
- Q15047
-